It has a high affinity to GLP-1R, strongly activating the GLP-1R Gs cAMP pathway without inducing measurable -arrestin recruitment signaling, which indicates it is a fully biased agonist
Semaglutide is the only GLP analog with a warning about diabetic retinopathy , which occured in 4.0% of patients (versus 2.7% with placebo)
This is a type of protein that the digestive system breaks down before it can enter the bloodstream
Pay close attention to: Inclusion and exclusion criteria Location (some trials require in-person visits) Frequency of check ins Study design, like whether the study is randomized and placebo-controlled (a placebo-controlled trial means not everyone receives the medication, which is an important consideration) Study duration (if youre in the placebo group, this is how long without treatment, too!) For instance, some retatrutide clinical trials are only enrolling people with obesity, which means you must be above a certain BMI to qualify
For patients, these cost saving measures can feel frustrating and counterproductive